Received Jul 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Y3Z9P | — |
it was not shaken vigorously before administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong technique in product usage process in a 92-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number Y3Z9P, expiry date 27-AUG-2027) for prophylaxis. On 26-JUN-2025, the patient received Boostrix. On 26-JUN-2025, an unknown time after receiving Boostrix, the patient experienced wrong technique in product usage process (Verbatim: it was not shaken vigorously before administration). The outcome of the wrong technique in product usage process was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 26-JUN-2025 The pharmacist reported that a patient that was administered with a Boostrix vaccine and it was not shaken vigorously before administration, which led to wrong technique in product usage process The reporter asked was there any advice on this and if they need to revaccinate or so. The Vaccine Administration Facility is the same as Primary Reporter